Implementation research to support the initiative on the elimination of kala azar from Bangladesh, India and Nepal – the challenges for diagnosis and treatment
Open Access
- 1 January 2008
- journal article
- Published by Wiley in Tropical Medicine & International Health
- Vol. 13 (1), 2-5
- https://doi.org/10.1111/j.1365-3156.2007.01974.x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Phase 4 Trial of Miltefosine for the Treatment of Indian Visceral LeishmaniasisThe Journal of Infectious Diseases, 2007
- Injectable Paromomycin for Visceral Leishmaniasis in IndiaThe New England Journal of Medicine, 2007
- Leishmaniasis and povertyTrends in Parasitology, 2006
- Comparative evaluation of parasitology and serological tests in the diagnosis of visceral leishmaniasis in India: a phase III diagnostic accuracy studyTropical Medicine & International Health, 2006
- Costs of patient management of visceral leishmaniasis in Muzaffarpur, Bihar, IndiaTropical Medicine & International Health, 2006
- Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar, IndiaTropical Medicine & International Health, 2006
- Rapid, Noninvasive Diagnosis of Visceral Leishmaniasis in India: Comparison of Two Immunochromatographic Strip Tests for Detection of Anti-K39 AntibodyJournal of Clinical Microbiology, 2006
- Amphotericin B Treatment for Indian Visceral Leishmaniasis: Conventional versus Lipid FormulationsClinical Infectious Diseases, 2004
- Oral Miltefosine for Indian Visceral LeishmaniasisThe New England Journal of Medicine, 2002
- Treatment of Indian visceral leishmaniasis with single or daily infusions of low dose liposomal amphotericin B: randomised trial Commentary: cost and resistance remain issuesBMJ, 2001